Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Mentholatum South Africa is a prominent consumer healthcare company specializing in the manufacture and distribution of over-the-counter (OTC) pharmaceuticals and personal care products. A subsidiary of the Japan-based Rohto Pharmaceutical, the company is best known for its market-leading topical analgesic brands, including Deep Heat and Deep Freeze. Their portfolio also encompasses well-recognized brands in skin care, lip care, and respiratory health, such as Oxy and Mentholatum Ointment. Operating from its headquarters and manufacturing facility in Cape Town, the company serves the South African and broader African markets with high-quality health and wellness solutions. The company maintains a strong presence in retail pharmacies and supermarkets, focusing on accessible self-care treatments.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Mentholatum South Africa.